Skip to content

United Kingdom · Ageing Society, Health & Nutrition

Laverock Therapeutics Ltd

Laverock Therapeutics Ltd is a UK early-stage company with 2 public funding or programme announcements on record, most recently 1 Jul 2026.

Companies House record (13508159)

Announcements

  • Innovate UK funding awarded

    £698,915 · Investment Accelerator grant; “MGS-CAR-T: Automated Design and High-throughput Discovery of Programmable Multiplex-Armour”; London

  • Innovate UK funding awarded

    £498,362 · Collaborative R&D grant; “Programmable gene silencing: non-disruptive miRNA harnessing in the design of a candidate ”; East of England

Is this your company?

Everything here comes from the public announcement or open dataset linked above. If something is wrong or out of date, or you would rather not be listed, email hello@capitalsignals.uk.

Not a recommendation

Support or selection by Innovate UK is not a sign that the company is a good investment. Most early-stage companies cannot be invested in by the public, and many fail.

All start-ups in Ireland and the UK